Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + tetracycline dual therapy with different tetracycline doses vs vonoprazan + high-dose amoxicillin for Helicobacter pylori infection
ChiCTR2500099200Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan, tetracycline and amoxicillin in Helicobacter pylori infection (3 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoint: Comparison of Helicobacter pylori eradication rate. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
vonoprazantetracyclineamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500099200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099200.